Last update 24 Mar 2025

Somatostatin Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Somatostain, SRIF-14, Stilamin
+ [2]
Action
agonists
Mechanism
SSTR1 agonists(Somatostatin receptor 1 agonists), SSTR2 agonists(Somatostatin receptor 2 agonists), SSTR3 agonists(Somatostatin receptor 3 agonists)
Originator Organization-
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Canada (10 Nov 1997)
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC78H108N18O21S2
InChIKeyGFYNCDIZASLOMM-HMAILDBGSA-N
CAS Registry54472-66-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Gastrointestinal Hemorrhage
China
08 Mar 1999
Pancreatitis
China
08 Mar 1999
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peptic UlcerPhase 2
Belgium
01 Sep 2000
Peptic UlcerPhase 2
France
01 Sep 2000
Peptic UlcerPhase 2
Greece
01 Sep 2000
Peptic UlcerPhase 2
Hungary
01 Sep 2000
Peptic UlcerPhase 2
Poland
01 Sep 2000
Peptic UlcerPhase 2
Spain
01 Sep 2000
Peptic Ulcer HemorrhagePhase 2
Belgium
01 Sep 2000
Peptic Ulcer HemorrhagePhase 2
France
01 Sep 2000
Peptic Ulcer HemorrhagePhase 2
Greece
01 Sep 2000
Peptic Ulcer HemorrhagePhase 2
Hungary
01 Sep 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
1,034
Octreotide
(Octreotide)
zlxhnrqtzp = sbzsemgvlx xivukusoqt (lsgzyxzhyn, amgsqmgjsg - gluesjwils)
-
19 Mar 2018
(Somatostatin)
zlxhnrqtzp = cstgmzrkhv xivukusoqt (lsgzyxzhyn, jsoyreltbo - fybkppawxu)
Not Applicable
Meningioma
somatostatin receptors
17
qhwkfbnqkm(eiyiwrhfel) = fefzmpjiwm mcdrlzpsul (gfzwcvpuzw )
Positive
01 Nov 2014
Not Applicable
Meningioma
somatostatin receptors
17
cesstmvgme(udtdraxago) = Toxicity was uncommon (2 patients) and manageable fgjecpmeqm (wwylowgomd )
Negative
01 Sep 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free